RNA Outsourcing Resources

1. The Future Of Gene Therapy Logistics – A Pivotal Moment 2/4/2025

   Ensure the safe, reliable, and future-ready delivery of gene therapies with cutting-edge temperature-controlled logistics solutions.

2. How Baby KJ Is Ushering In A New Era In CRISPR Medicine 8/5/2026

   A personalized gene-editing therapy was developed in months, showcasing how collaboration, manufacturing innovation, and regulatory alignment can accelerate treatments for rare diseases.

3. Standardization Where It Matters Most 3/2/2026

   Freezing doesn’t ensure consistency. Standardized cryopreservation removes site‑to‑site variability, providing predictable starting materials and lowering scientific and operational risk.

4. Treating Deficiencies In Employee Training And Mentorship 5/3/2024

   Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.

5. Clinical Research Is A Delicate Ecosystem 4/18/2024

   Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing essential support and resources that empower it to thrive in its objectives and endeavors.

6. Choosing A CDMO That Can Grow With A Viral Program 10/21/2026

   Viral modalities demand more from CDMO selection: relevant experience, rigorous tech transfer, analytical readiness, and a clear path to scale matter more than equipment alone.

7. Contract Design And Development Vs. In-House: Finding The Best Fit 11/18/2024

   Outsourcing medical device R&D to Contract Development Organizations (CDOs) aids innovation, scales resources, and overcomes constraints. Strategic evaluation ensures successful partnerships.

8. How To Double Up With A CDMO To Reduce Risk 12/12/2025

   Parallel operations with a CDMO can reduce risk and accelerate timelines by enabling simultaneous process development and manufacturing. Learn how this approach supports facility design.

9. Regulatory Readiness Is Built Early 8/3/2026

   Building regulatory readiness early in cell and gene therapy development protects product integrity, prevents costly delays, and secures long-term program viability.

10. 3 Services Your Biopharmaceutical Supply Chain Partner Should Offer 5/31/2023

    Finding an experienced partner dedicated to reducing risk of contamination and capable of growing with you as project advances through clinical trial stages is essential.